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If the University of Cape Town’s Lung 
Institute was a long-distance runner it 
would have the capacity to consistently 
outstrip many other peer research outfits 
in the country, garnering marathon medals 
by the fist-full.
The trouble is, despite its impressive 
international and local achievements, the 
fully autonomous institute has relatively few 
domestic peers – a tragic fact that scientific 
and business leaders are belatedly noticing, 
generating a faint new ray of hope. A recent 
study on clinical research and related training 
in South Africa by 13 of the country’s 
top scientists concluded that internal 
disinvestment by government agencies 
is threatening to kill clinical research.1 It 
is within this context that a far-sighted 
Professor Eric Bateman managed to convince 
the then Dean of Medicine, Professor JP van 
Niekerk and Vice-Chancellor of UCT, Dr 
Mamphela Ramphele, to build with mainly 
outside funding (Boehringer Ingelheim 80% 
plus Bateman’s own research-generated ‘nest 
egg’ funds), an ‘experimental’ stand-alone 
research facility. The aim was to take the 
study and management of lung diseases out 
of the highly specialised realm of hospital 
clinical services and render them relevant to 
every aspect of the problem: epidemiology, 
prevention, treatment and health system 
interventions, especially by engaging 
communities.
Professor Bateman wanted to create 
what he calls a ‘light on its feet’ (read 
‘unencumbered by bureaucracy’) public/
private body that would add value to both 
the university and society in general. ‘Over-
regulation is the enemy of enterprise,’ the 
tall, highly acclaimed marathon runner* and 
scientist believes.
Streaking ahead of traditional 
research models 
It proved a brilliant move, yielding concrete 
results beyond the visionary’s wildest hopes. 
That was ten years ago. Today academic 
health complexes are in crisis due to the 
lack of both a national governance structure 
and an integrated funding framework that 
leave health science faculties at the mercy 
of differing provincial funding priorities. 
Because of the absence of what (legally) 
should be a national function, academic 
health complex leaders are often at a loss as 
to whom to approach to secure enough funds 
to carry out critical functions that serve both 
the nation and their own region.2
Contrast this with the Lung Institute, with 
an annual budget that has risen from R3 
million initially to R40 million today, due 
almost solely to the revenue generation success 
of its research output. The Institute and its 
acclaimed Knowledge Translation Unit (KTU) 
have changed the way asthma is monitored 
and managed world-wide, provided innovative 
training and task shifting in the management 
of common lung diseases and HIV/AIDS (its 
model adopted nationally after a pilot run in the 
Free State showed hugely improved outcomes), 
and provides gold-standard consulting on 
allergies. Its Centre for Tuberculosis Research 
Innovation has garnered an international 
reputation for evaluating new TB drugs with 
exciting promise for treating extreme drug-
resistant (XDR) TB and multidrug-resistant 
(MDR) TB.
One of Professor Bateman’s research 
papers was the most cited article in the 
American Journal of Respiratory and Critical 
Care Medicine for three successive years and 
he was subsequently appointed Chair of the 
Science Committee of the Global Initiative 
for Asthma (GINA), and of its board.
Quantifying the problem
The Lung Institute pioneered community-
based surveys of the burden of lung diseases 
in South Africa, enabling, for the first time, 
comparisons with statistics from other 
countries. (We now know that in adults 
one in three local people are at risk of 
HIV-related lung infections, one in eight 
bear the scars of previous pulmonary TB, 
while in children, one in eight suffer from 
asthma. Respiratory allergies affect one in 
three children.)
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Surprising findings on chronic obstructive 
pulmonary disease (COPD), better known 
as emphysema, were also made, revealing 
not just tobacco smoking as the cause, but 
that South Africa carries a heavy burden of 
domestic, occupational and environmental 
air pollution, with TB also playing a role. 
One in four adult South Africans over the 
age of 40 today shows symptoms of COPD. 
Professor Bateman explains that, as in most 
developing countries, the use of fossil fuels in 
homes for cooking and heating is the major 
contributor to the high COPD prevalence 
(and, incidentally, household injuries). 
The WHO has since recognised the global 
burden of respiratory diseases (particularly 
in developing countries), and now includes 
chronic lung diseases as one of the four 
major groups of chronic disease requiring 
prioritisation for international action.
Another ground-breaking success story 
is the institute’s development, in 2001, 
of a practical approach to lung health in 
South Africa (PALSA), initially in response 
to a request from a struggling, doctor-
impoverished Free State Department of 
Health. The question was how to develop 
the capacity to handle the range of lung and 
other chronic diseases in a resource-poor 
setting.
Turning research into 
practical solutions
The Lung Institute’s KTU, headed by Drs 
Beverly Draper and Lara Fairall, developed 
guidelines and provided on-site training 
to equip nurses to diagnose and manage 
respiratory diseases, including TB. This 
evolved into a ground-breaking task-shifting 
programme called PALSA-Plus which 
consolidated uncomplicated antiretroviral 
therapy (ART)-eligible adults to primary 
health care facilities where appropriately 
trained nurses could treat them, thus 
freeing up scarcer doctors to concentrate 
on children and other more complex cases. 
The programmes have since become the 
norm across most South African provinces, 
improving TB detection in the Free State 
by 70% and asthma management by 80%. 
To date more than 110 000 copies of the 
guidelines have been distributed and more 
than 12 000 primary care nurses trained by 
some 900 facility trainers taught by the KTU 
team at the Lung Institute. The work was 
recently customised and implemented in 
Malawi and is being adapted for other sub-
Saharan African countries.
All this in a climate that has Deans of 
Medicine across the country (to mention 
professors of just one health care discipline) 
sighing in desperation over the government 
funding morass. Professor Bateman told 
Izindaba that the world’s major donors 
were shifting their focus to entrepreneurial 
institutions that could sustain themselves 
and make major impacts on society.
‘We’ve gone from something that was 
considered an experiment to outcomes 
that you’d want to replicate elsewhere – yet 
nobody seems to have yet got excited enough 
to (also) do it (create a stand-alone research 
centre)! Most universities know how to 
spend money but not how to make it. Sure, 
you need the right skills mix but you can buy 
those in,’ he argues. The Institute brings in the 
equivalent of more than 10% of UCT’s entire 
Health Sciences Faculty research budget and 
is a wholly owned subsidiary, plowing all 
its profits into educational outreach, self-
initiated projects and ventures. It has the 
ability to fund several PhD students and 
risk millions on developing new approaches 
which, if they show promise, will attract 
additional outside funding.
‘We effectively use some of these funds 
as venture capital on new activities. It’s the 
equivalent of small business development, 
but in the science realm,’ Professor Bateman 
says. Over a decade ago he realised that 
neither the State (via the university) nor 
the Medical Research Council were going 
to front up the money needed for the vital 
research he had in mind, ‘so we needed to be 
light enough on our feet and source money 
through research, making deals easily rather 
than prolonging lengthy bureaucracy’.
Does he now lobby for the replication 
of his research model nation-wide? ‘I put 
my head down on this venture without 
trying to proselytise. I try to put in a word 
where I can, but I don’t see my mission as 
trying to tell the university how it should 
be run. There are people paid to do that. I’d 
like to see them take a long serious look at 
what we’ve been doing and consider more 
outreach programmes. I do think they’d do 
much better by creating more entities like 
this. There is mention of a similar institute 
in the mental health area at UCT. As for us, 
we’re on the brink of our work being used 
internationally – the funding is always there 
for the right ventures.’
Sustainable, entrepreneurial 
= society benefits
Professor Bateman has ensured sustainability 
not only through the research initiatives of 
his five specialist units at the Institute, but 
also by cherry-picking the best financial 
advisors he could find from business, the 
Graduate School of Business and UCT.
The Academy of Science of South Africa, 
whose study entitled ‘Revitalising clinical 
research in South Africa’ was published in 
November 2009, called on government to 
raise the health research and development 
(R&D) spend from 13% to 20% of overall 
R&D spend (currently 0.7% of GDP and 
at bare minimum needing to reach 2% of 
GDP). Their report highlighted the lack 
of a national plan to provide co-ordinated 
support for the education and development 
of clinical researchers and said that more 
than half of the total expenditure of clinical 
research in South Africa was by the private 
sector.
Perhaps more lean, large-lunged private 
marathon runners are required to help their 
comrades over the social upliftment line.
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